US · Healthcare

Harrow Health Inc (HROW)

Drug Manufacturers - Specialty & Generic

Harrow Health Inc (HROW) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HROW

P/E ratio

18.00

Harrow Health Inc (HROW) — FAQ

What is HROW's P/E ratio?

The price-to-earnings (P/E) ratio for Harrow Health Inc (HROW) is 18.00 (data as of 2026-03-24).

Does Harrow Health Inc pay a dividend?

Dividend yield is not available in the current snapshot for Harrow Health Inc (HROW). Check the MyAverix Finance app for the latest dividend data.

What sector is Harrow Health Inc in?

Harrow Health Inc (HROW) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is HROW listed on?

HROW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)